Can glucose-lowering medications improve outcomes in non-diabetic heart failure patients? A Bayesian network meta-analysis

• Main Authors: Yeong, Trevor, Mai, Aaron Shengting, Lim, Oliver ZH, Ng, Cheng Han, Chin, Yip Han, Tay, Phoebe, Lin, Chaoxing, Muthiah, Mark, Khoo, Chin Meng, Dalakoti, Mayank, Loh, Poay-Huan, Chan, Mark, Yeo, Tiong-Cheng, Foo, Roger, Wong, Raymond, Chew, Nicholas WS, Lin, Weiqin
• Other Authors: MEDICINE
• Format: Article
• Language: English
• Published: WILEY PERIODICALS, INC 2022
• Subjects: Science & Technology; Life Sciences & Biomedicine; Cardiac & Cardiovascular Systems; Cardiovascular System & Cardiology; Heart failure; Sodium-glucose cotransporter 2 inhibitors; Glucagon-like peptide 1 receptor agonists; Metformin; GLP-1 RECEPTOR AGONISTS; CARDIOVASCULAR OUTCOMES; EJECTION FRACTION; SGLT2 INHIBITORS; MORTALITY; LIRAGLUTIDE; EMPAGLIFLOZIN; HOSPITALIZATION; DISEASE; DEATH
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/219418
• Institution: National University of Singapore

10.1002/ehf2.13822